Streetbeat News

Products Services

AIM

AIM ImmunoTech shares rose following the announcement of a new U.S. patent for Ampligen, aimed at treating endometriosis.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 12:48 pm

AIM

AIM ImmunoTech has been granted U.S. Patent No. 12,102,649 for its drug Ampligen, which is intended for the treatment of endometriosis. This patent could potentially enhance AIM ImmunoTech's market position and future revenue streams.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 12:46 pm

LPTH

LightPath Technologies has received $0.5 million in Phase 2 funding from the U.S. Defense Department to qualify additional BlackDiamond glasses as substitutes for germanium. This follows a successful Phase 1 where three materials were qualified. Phase 2 will cover six more materials advancing to MRL-9 for defense applications.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 12:45 pm

EVGO

EVgo Inc. has received a conditional commitment for a $1.05 billion loan guarantee from the U.S. Department of Energy to expand its fast charging network across the U.S. This financing will support the construction of approximately 7,500 new DC fast charging stalls.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 12:41 pm

EVGO

EVgo has received a $1.05 billion conditional commitment for a DOE loan guarantee to expand its public fast charging network across the U.S. This financing will aid in constructing around 7,500 new DC fast charging stalls in community locations.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 12:40 pm

ATNF

180 Life Sciences Corp. (NASDAQ:ATNF) has announced the acquisition of an advanced gaming technology platform, marking a strategic shift into the iGaming market. The company has also made progress on its CBD formulation and strengthened its balance sheet by settling liabilities. The acquisition is expected to help meet Nasdaq's listing requirements and provide a competitive edge in the blockchain casino market.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 12:40 pm

SHIBUSD

Shiba Inu's burn rate has increased significantly, but technical indicators suggest potential price weakness. Despite a 29% surge in September, SHIB's technicals show a long-term downtrend, with decreased large transaction volume and daily active addresses.

Portfolio Pulse from Khyathi Dalal

October 03, 2024 | 12:38 pm

IPW

iPower Inc. (NASDAQ:IPW) has partnered with Zyla by Ant International to enable Zyla's clients to expand sales on U.S. online marketplaces via iPower's SuperSuite platform. This partnership marks iPower's first step towards integrating supply chain financial services, enhancing its platform's value.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 12:36 pm

MGRX

MangoRx has launched an oral version of Tirzepatide, a GLP-1 receptor agonist, aimed at providing advanced weight loss solutions. The product is priced at $399 per month.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 12:35 pm

ICCT

iCoreConnect Inc. (NASDAQ:ICCT) has acquired the assets of the Healthcare Circle of Excellence, enhancing its position in the healthcare sector. This strategic acquisition aims to provide comprehensive solutions to healthcare practices, fostering independence and financial success.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 12:35 pm